Amphastar Pharmaceuticals Inc
NASDAQ:AMPH

Watchlist Manager
Amphastar Pharmaceuticals Inc Logo
Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
Watchlist
Price: 45.48 USD -4.67% Market Closed
Market Cap: 2.2B USD
Have any thoughts about
Amphastar Pharmaceuticals Inc?
Write Note

Wall Street
Price Targets

AMPH Price Targets Summary
Amphastar Pharmaceuticals Inc

Wall Street analysts forecast AMPH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AMPH is 62.73 USD with a low forecast of 55.55 USD and a high forecast of 73.5 USD.

Lowest
Price Target
55.55 USD
22% Upside
Average
Price Target
62.73 USD
38% Upside
Highest
Price Target
73.5 USD
62% Upside

AMPH Last Price Targets
Amphastar Pharmaceuticals Inc

The latest public price target was made on Aug 8, 2024 by David Amsellem from Piper Sandler , who expects AMPH stock to rise by 45% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
David Amsellem
Piper Sandler
66 USD
Upside 45%
3 months ago
Aug 8, 2024
Amphastar Pharmaceuticals (AMPH) PT Lowered to $66 at Piper Sandler
StreetInsider
David Amsellem
Piper Sandler
71 USD
Upside 56%
5 months ago
May 23, 2024
Piper Sandler Reiterates Overweight Rating on Amphastar Pharmaceuticals (AMPH)
StreetInsider
David Amsellem
Piper Sandler
Price Target 66 USD
Upside/Downside 45%
View Source
David Amsellem
Piper Sandler
Price Target 71 USD
Upside/Downside 56%
View Source
Amphastar Pharmaceuticals Inc Competitors:
Price Targets
EOLS
Evolus Inc
95% Upside
002821
Asymchem Laboratories Tianjin Co Ltd
16% Upside
HROW
Harrow Health Inc
17% Upside
605507
Guobang Pharma Ltd
16% Upside
300765
CSPC Innovation Pharmaceutical Co Ltd
51% Upside
BSEM
Biostem Technologies Inc
6% Upside
JBCHEPHARM
J B Chemicals and Pharmaceuticals Ltd
21% Upside
XERS
Xeris Biopharma Holdings Inc
51% Upside

Revenue
Forecast

Revenue Estimate
Amphastar Pharmaceuticals Inc

For the last 8 years the compound annual growth rate for Amphastar Pharmaceuticals Inc's revenue is 12%. The projected CAGR for the next 3 years is 12%.

12%
Past Growth
12%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Amphastar Pharmaceuticals Inc

The compound annual growth rate of Amphastar Pharmaceuticals Inc's operating income for the next 3 years is 17%.

N/A
Past Growth
17%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Amphastar Pharmaceuticals Inc

The compound annual growth rate of Amphastar Pharmaceuticals Inc's net income for the next 3 years is 21%.

N/A
Past Growth
21%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AMPH's stock price target?
Price Target
62.73 USD

According to Wall Street analysts, the average 1-year price target for AMPH is 62.73 USD with a low forecast of 55.55 USD and a high forecast of 73.5 USD.

What is Amphastar Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
12%

For the last 8 years the compound annual growth rate for Amphastar Pharmaceuticals Inc's revenue is 12%. The projected CAGR for the next 3 years is 12%.

What is Amphastar Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
17%

The compound annual growth rate of Amphastar Pharmaceuticals Inc's operating income for the next 3 years is 17%.

What is Amphastar Pharmaceuticals Inc's Net Income forecast?
Projected CAGR
21%

The compound annual growth rate of Amphastar Pharmaceuticals Inc's net income for the next 3 years is 21%.

Back to Top